Reuters logo
BRIEF-InMed Pharmaceuticals ‍announces additional pre-clinical results in development of INM-405
October 17, 2017 / 10:12 AM / 2 months ago

BRIEF-InMed Pharmaceuticals ‍announces additional pre-clinical results in development of INM-405

Oct 17 (Reuters) - InMed Pharmaceuticals Inc

* InMed Pharmaceuticals Inc - ‍announced additional pre-clinical results in development of INM-405 for treatment of pain​

* InMed Pharma- ‍results show peripheral application of some cannabinoid compounds effective in treating craniofacial muscle pain disorders, without observed CNS side effects​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below